Viewing Study NCT01425294


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2025-12-26 @ 2:06 AM
Study NCT ID: NCT01425294
Status: TERMINATED
Last Update Posted: 2017-12-05
First Post: 2011-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module